Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection.
Ribeiro PAF, Dias DS, Lage DP, Martins VT, Costa LE, Santos TTO, Ramos FF, Tavares GSV, Mendonça DVC, Ludolf F, Gomes DA, Rodrigues MA, Chávez-Fumagalli MA, Silva ES, Galdino AS, Duarte MC, Roatt BM, Menezes-Souza D, Teixeira AL, Coelho EAF.
Ribeiro PAF, et al. Among authors: tavares gsv.
Mol Immunol. 2019 Feb;106:108-118. doi: 10.1016/j.molimm.2018.12.025. Epub 2018 Dec 27.
Mol Immunol. 2019.
PMID: 30594673